Table 2.
(A) Borrelia-induced Non-Lyme neuroborreliosis patients that were positive in the ELISPOT (≥5 spots) assay in cerebrospinal fluid, classified into different diagnostic groups; (B) Non-Lyme neuroborreliosis patients with spontaneous secretion of 15 spots or more, classified into different diagnostic groups.
| Diagnostic groups Non-Lyme neuroborreliosis | Number (n = 19) |
| Pain/myalgia/arthralgia/fatigue | n = 6 |
| Other infection Pyelonephritis Unspecific infection Tendinitis Tooth infection |
n = 4 |
| Other CNS disease Alzheimer’s disease Neuropathy Sensibility disorder |
n = 3 |
| Autoimmune Collagenosis Rheumatoid arthritis |
n = 2 |
| Inflammatory CNS disease Tick-borne encephalitis |
n = 2 |
| Endocrine Hypothyroidism |
n = 1 |
| Lymphoma | n = 1 |
| (A) | |
| Diagnostic groups Non-Lyme neuroborreliosis | Number (n = 23) |
| Pain/myalgia/arthralgia/fatigue | n = 8 |
| Autoimmune Mb Reiter Collagenosis Rheumatoid arthritis |
n = 4 |
| Other CNS disease Epilepsy Neuropathy Sensibility disorder |
n = 4 |
| Other infection Pyelonephritis Tooth infection Herpes keratitis |
n = 3 |
| Inflammatory CNS disease Tick-borne encephalitis |
n = 2 |
| Lymphoma | n = 1 |
| Unknown diagnosis | n = 1 |
| (B) | |